<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17238/PmJ1609-1175.2018.4.95-100</article-id><article-id custom-type="elpub" pub-id-type="custom">pmj-294</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PUBLIC HEALTH ORGANIZATION</subject></subj-group></article-categories><title-group><article-title>Туберкулез с множественной и широкой лекарственной устойчивостью в Омской области: основные тенденции и характеристики</article-title><trans-title-group xml:lang="en"><trans-title>Multidrug-resistant and extensively drug-resistant tuberculosis in the Omsk region: trends and characteristics</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пасечник</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pasechnik</surname><given-names>O. A.</given-names></name></name-alternatives><email xlink:type="simple">opasechnik@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зимогляд</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zimoglyad</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ярусова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yarusova</surname><given-names>I. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Витрив</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vitriv</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Блох</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Blokh</surname><given-names>A. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Омский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Omsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Центр гигиены и эпидемиологии в Омской области</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Health and Epidemiology Center in the Omsk Region</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Клинический противотуберкулезный диспансер</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinical Antituberculous Dispensary</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2018</year></pub-date><volume>0</volume><issue>4</issue><fpage>95</fpage><lpage>100</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пасечник О.А., Зимогляд А.А., Ярусова И.В., Витрив С.В., Блох А.И., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Пасечник О.А., Зимогляд А.А., Ярусова И.В., Витрив С.В., Блох А.И.</copyright-holder><copyright-holder xml:lang="en">Pasechnik O.A., Zimoglyad A.A., Yarusova I.V., Vitriv S.V., Blokh A.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/294">https://www.tmj-vgmu.ru/jour/article/view/294</self-uri><abstract><p>На территории Омской области в 2006-2017 гг. выявлены качественные и количественные изменения параметров эпидемического процесса туберкулезной инфекции. На фоне снижения заболеваемости туберкулезом до уровня 62,2 на 100 тыс. населения наблюдалась смена возрастной структуры впервые выявленных больных, рост доли пациентов, коинфицированных ВИЧ до 22 %, увеличение доли выделителей микобактерий с множественной и широкой устойчивостью возбудителя. Заболеваемость населения этой формой туберкулеза составила 1,6, а распространенность - 13,6 на 100 тыс. населения и характеризовалась выраженной тенденцией к росту. В сложившихся условиях региональная система эпидемиологического надзора требует новых подходов к оптимизации с учетом изменений параметров эпидемического процесса.</p></abstract><trans-abstract xml:lang="en"><p>Objective. Micobacteria resitant to antituberculosis drugs endanger the fight against tuberculosis worldwide. Methods. A retrospective epidemiological study was conducted, based on the observation of the epidemic process of tuberculosis infection in 2006-2017 in Omsk region. We used the data of federal statistical surveillance forms, and also bacteriograms of tuberculosis patients. Results. Against the background of a decrease in the incidence of tuberculosis to 62.2 per 100 thousand of the population, the age structure of newly diagnosed patients was changed: an increase in the proportion of people aged 35-44 from 19.2 to 31.9 %, while reducing the proportion of 18-24 y.o. from 13.8 to 6.1 % and 45-54 y.o. from 21.8 to 13.5 %. The number of patients co-infected with the human immunodeficiency virus (from 1.4 to 22 %) has increased. The incidence of bacterial excretion increased from 39.8 to 56 %. 51.8 % of mycobacterial isolates were characterized by different types of drug resistance. Among newly-detected bacterial invaders, the proportion of patients with multidrug-resistant mycobacteria increased from 24.1 to 30.5 %. The incidence of tuberculosis with extensively drug-resistant tuberculosis was 1.6, and prevalence was 13.6 per 100,000 of population and was characterized by a pronounced upward trend. Conclusions. Under the circumstances, the regional system of epidemiological surveillance will require new approaches to optimization, taking into account changes in the parameters of the epidemic process.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>туберкулез</kwd><kwd>лекарственная устойчивость</kwd><kwd>заболеваемость</kwd><kwd>распространенность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tuberculosis</kwd><kwd>drug resistance</kwd><kwd>morbidity</kwd><kwd>prevalence</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Нечаева О.Б. Эпидемическая ситуация по ВИЧ-инфекции в России. URL: http://mednet.ru/images/stories/files/ CMT/2016vich.pdf (дата обращения: 18.04. 2018 г.)</mixed-citation><mixed-citation xml:lang="en">Нечаева О.Б. Эпидемическая ситуация по ВИЧ-инфекции в России. URL: http://mednet.ru/images/stories/files/ CMT/2016vich.pdf (дата обращения: 18.04. 2018 г.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Стерликов С.А., Галкин В.Б., Попова Н.М. [и др.]. Определение ожидаемой распространенности туберкулеза с множественной и широкой лекарственной устойчивостью методом математического моделирования в учреждениях уголовноисполнительной системы Российской Федерации // Медицинский альянс. 2018. № 1. С. 33-41</mixed-citation><mixed-citation xml:lang="en">Стерликов С.А., Галкин В.Б., Попова Н.М. [и др.]. Определение ожидаемой распространенности туберкулеза с множественной и широкой лекарственной устойчивостью методом математического моделирования в учреждениях уголовноисполнительной системы Российской Федерации // Медицинский альянс. 2018. № 1. С. 33-41</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Туберкулез в Российской Федерации 2011 г.: аналитический обзор статистических показателей, используемых в Российской Федерации и в мире. М., 2013. 280 с</mixed-citation><mixed-citation xml:lang="en">Туберкулез в Российской Федерации 2011 г.: аналитический обзор статистических показателей, используемых в Российской Федерации и в мире. М., 2013. 280 с</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральные клинические рекомендации по диагностике и лечению туберкулеза органов дыхания с множественной и широкой лекарственной устойчивостью возбудителя. URL: http://roftb.ru/netcat_files/doks2015/3final.pdf (дата обращения: 24.04.2018 г.)</mixed-citation><mixed-citation xml:lang="en">Федеральные клинические рекомендации по диагностике и лечению туберкулеза органов дыхания с множественной и широкой лекарственной устойчивостью возбудителя. URL: http://roftb.ru/netcat_files/doks2015/3final.pdf (дата обращения: 24.04.2018 г.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Anti-tuberculosis drug resistance in the world: the WHO/ IUATLD global project on anti-tuberculosis drug resistance surveillance 2002-2007. Geneva, Switzerland: World Health Organization, 2008. 120 p.</mixed-citation><mixed-citation xml:lang="en">Anti-tuberculosis drug resistance in the world: the WHO/ IUATLD global project on anti-tuberculosis drug resistance surveillance 2002-2007. Geneva, Switzerland: World Health Organization, 2008. 120 p.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Eker В., Ortmann J., Migliori G.B. [et al]. Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany // Emerging Infectious Diseases. 2008. Vol. 14, No. 11. P. 1700-1706.</mixed-citation><mixed-citation xml:lang="en">Eker В., Ortmann J., Migliori G.B. [et al]. Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany // Emerging Infectious Diseases. 2008. Vol. 14, No. 11. P. 1700-1706.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Faustini A., Hall A.J., Perucci C.A. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review // Thorax. 2006.Vol. 61. P 158-163.</mixed-citation><mixed-citation xml:lang="en">Faustini A., Hall A.J., Perucci C.A. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review // Thorax. 2006.Vol. 61. P 158-163.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gandhi N.R., Nunn P, Dheda K. [et al.]. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis // Lancet. 2010. Vol. 375, No. 9728. P 1830-1843.</mixed-citation><mixed-citation xml:lang="en">Gandhi N.R., Nunn P, Dheda K. [et al.]. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis // Lancet. 2010. Vol. 375, No. 9728. P 1830-1843.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Global tuberculosis report; Document 2017 (WHO/HTM/ TB/2004.343) [Internet] Geneva: World Health Organization, 2017. [cited 2018 May 4]. URL: http://apps.who.int/iris/bitstream/handle/10665/259366/9789241565516-eng.pdf (date of access: 24.04.2018).</mixed-citation><mixed-citation xml:lang="en">Global tuberculosis report; Document 2017 (WHO/HTM/ TB/2004.343) [Internet] Geneva: World Health Organization, 2017. [cited 2018 May 4]. URL: http://apps.who.int/iris/bitstream/handle/10665/259366/9789241565516-eng.pdf (date of access: 24.04.2018).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">He X.-C., Tao N.-N., Liu Y. [et al.]. Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China // BMC Infect. Dis. 2017. Vol. 17, No. 1. P. 555.</mixed-citation><mixed-citation xml:lang="en">He X.-C., Tao N.-N., Liu Y. [et al.]. Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China // BMC Infect. Dis. 2017. Vol. 17, No. 1. P. 555.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Marks S.M., Flood J., Seaworth В. [et al.]. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007 // Emerging Infectious Diseases. 2014. Vol.20, No. 5. P 812-821.</mixed-citation><mixed-citation xml:lang="en">Marks S.M., Flood J., Seaworth В. [et al.]. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007 // Emerging Infectious Diseases. 2014. Vol.20, No. 5. P 812-821.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Qi Y.-C., Ma M.-J., Li D.-J. [et al.]. Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous region, China // PLoS ONE. 2012. Vol. 7, No. 2. P. e32103.</mixed-citation><mixed-citation xml:lang="en">Qi Y.-C., Ma M.-J., Li D.-J. [et al.]. Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous region, China // PLoS ONE. 2012. Vol. 7, No. 2. P. e32103.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Raviglione M. XDR-TB: entering the post-antibiotic era? // Int. J. Tuberc. Lung Dis. 2006. Vol. 10. P 1185-1187.</mixed-citation><mixed-citation xml:lang="en">Raviglione M. XDR-TB: entering the post-antibiotic era? // Int. J. Tuberc. Lung Dis. 2006. Vol. 10. P 1185-1187.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Systematic screening for active tuberculosis: principles and recommendations: Document no 2013 (WHO/HTM/ TB/2013b04) [Internet] Geneva: World Health Organization; 2013. [cited 2018 May]. URL: http://www.who.int/tb/publications/Final_TB_Screening_guidelines.pdf (date of access: 24.04.2018).</mixed-citation><mixed-citation xml:lang="en">Systematic screening for active tuberculosis: principles and recommendations: Document no 2013 (WHO/HTM/ TB/2013b04) [Internet] Geneva: World Health Organization; 2013. [cited 2018 May]. URL: http://www.who.int/tb/publications/Final_TB_Screening_guidelines.pdf (date of access: 24.04.2018).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wright A., Zignol M., Van Deun A. [et al.]. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance // Lancet. 2009. Vol. 373. P. 1861-1873.</mixed-citation><mixed-citation xml:lang="en">Wright A., Zignol M., Van Deun A. [et al.]. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance // Lancet. 2009. Vol. 373. P. 1861-1873.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
